MCL-1 INHIBITORS

The present disclosure generally relates to compounds and pharmaceutical compositions that may be used in methods of treating cancer.

Saved in:
Bibliographic Details
Main Authors Kobayashi, Tetsuya, Guerrero, Juan A, Medley, Jonathan W, Lazerwith, Scott E, Hwang, Tae H, Venkataramani, Chandrasekar, Kato, Darryl, Hurtley, Anna E, Squires, Neil H, Watkins, William J, Knox, John E, Chu, Hang, Newby, Zachary, Jiang, Lan, Lin, David W, Naduthambi, Devan, Tsui, Vickie H, Li, Xiaofen, Mitchell, Michael L, Yang, Hong
Format Patent
LanguageEnglish
Published 21.11.2019
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:The present disclosure generally relates to compounds and pharmaceutical compositions that may be used in methods of treating cancer.
Bibliography:Application Number: US201916410457